Labdentus - Company finances
|
EUR
|
2018
From: 2018-09-25
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 7,314 | 37,848 | 38,275 | 63,622 | 60,829 | 54,395 | 50,270 | 61,090 |
| Profit before tax | 2,358 | 12,748 | 11,783 | 27,041 | 17,245 | 14,746 | 1,387 | 21,064 |
| Net profit | 2,280 | 12,441 | 11,558 | 26,074 | 16,863 | 14,513 | 1,387 | 20,156 |
| Equity | 2,281 | 13,635 | 18,587 | 37,377 | 36,536 | 35,569 | 28,513 | 37,722 |
| Liabilities | - | - | - | - | 8,727 | 5,726 | 2,122 | 3,258 |
| Non-current assets | 0 | 10,932 | 8,601 | 19,067 | 14,643 | 11,274 | 12,411 | 12,968 |
| Current assets | 5,606 | 7,371 | 11,149 | 28,928 | 30,620 | 30,021 | 18,224 | 28,012 |
| Total assets | 5,606 | 18,303 | 19,750 | 47,995 | 45,263 | 41,295 | 30,635 | 40,980 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 401 | 1,306 | 1,289 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +417.5% | +1.1% | +66.2% | -4.4% | -10.6% | -7.6% | +21.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 40.7% | 68.0% | 58.5% | 54.3% | 37.3% | 35.1% | 4.5% | 49.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 91.2% | 62.2% | 69.8% | 46.2% | 40.8% | 4.9% | 53.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 31.2% | 32.9% | 30.2% | 41.0% | 27.7% | 26.7% | 2.8% | 33.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 32.2% | 33.7% | 30.8% | 42.5% | 28.3% | 27.1% | 2.8% | 34.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.2 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Labdentus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-01 | 2026-08-06 | 45.59 |
| 2026-05-27 | 2026-06-30 | 69.16 |
| 2026-05-22 | 2026-05-26 | 0.01 |
| 2026-05-03 | 2026-05-21 | 104.06 |
| 2026-04-15 | 2026-04-30 | 104.06 |
| 2025-12-10 | 2026-01-31 | 0.01 |
| 2025-07-14 | 2025-07-31 | 51.99 |
| 2023-07-19 | 2023-07-31 | 1253.76 |
Labdentus - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Labdentus is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-18 | 2026-09-02 | 0.84 |
| 2026-04-17 | 2026-05-03 | 0.54 |
| 2026-04-13 | 2026-04-16 | 1.38 |
| 2026-02-21 | 2026-04-12 | 0.54 |
| 2025-12-17 | 2026-02-16 | 0.54 |
| 2025-12-11 | 2025-12-16 | 1.38 |
| 2025-06-11 | 2025-12-10 | 0.54 |
| 2025-05-24 | 2025-06-10 | 0.86 |
| 2025-04-16 | 2025-05-23 | 0.58 |
| 2025-02-27 | 2025-04-15 | 0.54 |
| 2025-02-20 | 2025-02-26 | 197.0 |
| 2024-11-30 | 2025-01-24 | 9.07 |
| 2024-10-24 | 2024-11-29 | 9.28 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Labdentus, MB (code 304923319) is a Small partnership engaged in the manufacture of prosthetic appliances, implants and orthodontic devices. In 2025, revenue increased to €61.1K, up 21.5% year on year and 12.3% over two years. Net profit rose to €20.2K from €1.4K in 2024, lifting the profit margin to 33.0% after 2.8% a year earlier. The 2023–2025 trajectory shows a clear dip in 2024 followed by a strong rebound in 2025, with profit above the 2023 level of €14.5K. The balance sheet remained compact and conservatively financed: total assets were €41.0K, equity €37.7K and liabilities €3.3K at the end of 2025. Equity accounted for 92.0% of assets and the debt-to-equity ratio was 0.09, indicating limited leverage. Returns were strong in 2025, with ROE at 53.4% and ROA at 49.2%. Asset turnover stood at 1.49x, suggesting efficient use of the asset base.